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Introduction 
Summary 
Dendritic cells (DC) are often arranged in planar layers in tissues with 
high antigenic exposure, such as skin and mucosae. Providing an en face 
view, this arrangement optimizes in situ analysis regarding morphology 
(even of individual dendrites), topographic distribution (regular/clustered) 
and quantiﬁcation. The few reports on human genital DC usually utilize 
markers and conventional sections, restricting immunolabelling 
only to cell parts sectioned by the cut. To better assess DC in situ, we  
labelled epithelial sheets, prepared from fresh cervix biopsies, with anti-
dense DC network in a 
bodies to major histocompatibility complex (MHC)-CII, CD1a and Lang­
erin, revealing (with each of these markers) a 
planar-like, regular distribution. Using the hybrid capture system to detect 
the high-risk mucotropic human papilloma virus (HPV) group, 16 posit­
ive and ﬁve negative women were studied and the results were compared 
between these groups. DC frequency per area was substantially reduced 
(to � 50% for the three markers) in samples from all HPV-infected 
patients compared with samples from controls. Unlike HPV– samples, 
Langerin+ DC in HPV+ cervix exhibited a highly accentuated dendritic 
appearance. We believe this to be the ﬁrst study using these three DC-
restricted markers (Langerin, CD1a and MHC-CII) in cervical epithelial 
sheets from high-risk HPV+ donors and also the ﬁrst study to demon­
strate the morphological and quantitative changes triggered by high-risk 
HPV infection. Cervical DC reduction in early, premalignant high-risk 
HPV infection might represent viral subversion strategies interfering with 
efﬁcient antigen handling by the immune system’s peripheral sentinels, 
the DC, perhaps hampering appropriate recruitment and subsequent 
development of effector (cytotoxic) T cells. 
origin (e.g. microbial, inﬂammatory or cytokines), DC are 
induced to migrate from their peripheral locations into 
Dendritic cells (DC) constitute a system of highly special the nearest lymphoid tissues where they will usually local
ized antigen presenting cells (APC) that function as senti ize in the T cell areas.2,3 It is now clear that, apart from 
nel posts of the immune system, especially in peripheral the original antigen (Ag) or inﬂammatory stimuli, signals 
non lymphoid tissues that have a high antigenic exposure, like chemokines and chemokine receptors will function to 
such as the skin and mucosae.1 Under stimuli of diverse facilitate and guide DC trafﬁcking.4 This complex process 
Abbreviations: Ab, antibody; Ag, antigen; APC, antigen presenting cell; CIN, cervical intraepithelial neoplasia; CTL, cytotoxic 
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culminates in the appropriate delivery of processed Ag to 
lymphocytes and the initiation of efﬁcient immune 
responses. As T cells need Ag transportation and process
ing, their dependence on DC is an absolute requirement 
to efﬁciently initiate their functions as effector cells, 
and this holds for both CD4+ and CD8+ (cytotoxic) T 
lymphocytes.5 
Although DC have been described in the human female 
genital tract, especially in the cervix, these reports are scarce 
regarding healthy samples and are at least contradictory 
concerning human papilloma virus (HPV) infected tissues. 
Some researchers have found no changes, some have repor
ted an increased DC frequency, while others have found 
decreased DC numbers.6–8 This might be explained by the 
fact that the samples used may have been from HPV infec
ted subjects at different stages of the disease, or taken from 
different histological areas in each person. 
Potential subversion strategies of micro organisms to 
evade effector T cell responses could be either to attack 
the T cells directly (human immunodeﬁciency virus, for 
instance), or to interfere with the APC (like Mycobacte
rium tuberculosis),9 on which T cell responses are strictly 
dependent. 
Human cervical cancer is the ﬁrst recognized by the 
World Health Organization (WHO) as being 100% attrib
HPV.10,11utable to an infectious agent, the high risk 
More than 80% of the cases of this neoplasia occur in 
developing countries where good programmes for screen
ing, prevention or treatment are still awaiting implemen
tation. Nevertheless, excellent research, over a time period 
of 10 20 years, has been carried out on several aspects of 
this malignancy, including the clinical evolution and the 
classiﬁcations of this protracted disease; likewise, the 
complete genomes of many HPVs are known.12,13 
There are, however, gaps in the understanding of this 
cancer of infectious origin and the potential interactions 
with the local immune system in the female genital tract. 
For instance, by necessity, most patients with cervical 
cancer are ﬁrst seen and investigated when the disease has 
already evolved to a neoplastic stage, and perhaps this has 
made the research in the early phases of the HPV infec
tion less abundant. 
Likewise, studies of regional immune responses in the 
healthy, intact human female genital tract are rather scarce. 
Although it is assumed that HPV enters through micro
abrasions and infects basal epithelial stem cells using mech
anisms and molecules not yet elucidated,14 the type of 
immune responses (if any) occurring locally in the affected 
tissues during the early phases of HPV infection are virtu
ally unknown. Moreover, it seems that there is a poor 
inﬂammatory response under HPV infection during the 
early cervical intraepithelial neoplasia (CIN) phases.10,11 
At a systemic level it is known that antibodies (Abs) 
can be induced to L1 or to E7 viral proteins. However, in 
the case of L1, Abs might take months or years to 
appear,10 while antibodies to E7 are uncommon before 
the onset of the invasive disease, despite the fact that E7 
protein might have been expressed during the previous 10 
or 20 years. In any case, however, these Ab responses are 
clearly non protective because the disease continues to 
develop.15 
Cellular immunity to HPV, as assessed mainly by in vitro 
T cell reactivity, has been more difﬁcult to demonstrate, 
and reports are contradictory.10 However, despite the infec
tious origin of this neoplasia, and despite the chronicity of 
the infection, it seems that the cytotoxic T lymphocytes 
(CTL) of a substantial proportion of women have been 
found to be unresponsive to HPV.7 Faulty local (epithelial) 
Ag handling and processing has been proposed to account 
for this.10 There is one report, nonetheless, indicating that 
delayed type hypersensitivity (DTH) to E7 correlates well 
with the resolution of CIN.16 
At least part of the seemingly faulty (humoral and 
cellular) immune responses towards HPV might be 
explained by the fact that HPV infects basal epithelial 
stem cells, but for replication it apparently requires that 
these cells undergo differentiation. During differentiation, 
these cells transit from the basal cellular stratum towards 
the lumenal (external) side where the mature virions are 
ﬁnally produced and released. Moreover, HPV does not 
have a lytic phase; rather, it seems to induce cell prolifer
ation, thus lacking a viraemic stage during the infection, 
when dissemination and presentation of viral Ags would 
occur.17 Therefore, both systemically and in the local 
infected tissue, no or scarce possibilities of useful contacts 
exist between the HPV and the elements of the immune 
10,17system.
In an attempt to initiate in situ studies on the regional 
immune responses during the early stages of human 
female infection with high risk HPV, we selected two 
groups of Mexican women. This segregation was based on 
several, carefully evaluated, criteria, including a specialized 
clinical examination, laboratory tests, cytopathology, and 
the positivity or negativity for a set of high risk HPV, 
according to the hybrid capture method. Epithelial sheets 
from fresh cervical biopsies from these women were eval
uated for the presence, phenotype and frequency of DC, 
using three well established DC markers. 
Materials and methods 
Selection of patients and control subjects 
The protocol for this study was ﬁrst reviewed and 
approved by the local ethical board of the Regional Hos
pital of Pachuca, Mexico’s Health Secretariat, Hidalgo 
state. Non pregnant women who, during a period of 
13 months (2001 02), were referred for a colposcopic 
evaluation to the specialized gynecological services at the 
Regional Hospital because of an abnormal Pap smear, 
were considered for enrolment in the study. These women 
were carefully evaluated, which involved undertaking a 
complete gynaecological examination, including colpo
scopy, cytobrush, Pap smear and aceto white testing. 
Only those women who, by all criteria, were categorized 
as having low grade disease (CIN I) and with lesions large 
enough to provide biopsies, were considered, asked to 
participate in the study and requested to provide written, 
informed consent. CIN I was chosen because is an early 
premalignant lesion, usually in the so called transforma
tion zone (TZ) of the cervix, and associated with manifes
tations of HPV infection, such as koilocytosis. Of a total 
of 796 women attending the ﬁrst visit to this service dur
ing the period of October 2001 to October 2002, 23 were 
preselected on the basis of the results of the clinical evalu
ations mentioned above. Of these, after the clinical, labor
atory and histopathology evaluations, 16 were selected on 
the basis of their positivity for high risk HPV, according 
to the results obtained following analysis by the hybrid 
capture system kit (Digene, Gaithersburg, MD). Five 
women, undergoing hysterectomy for benign conditions, 
were included as controls, according to negative results 
when analysed by the criteria listed above, including gyn
ecological evaluations, the cytology results and the hybrid 
capture system kit. A further step was included in which 
the data of the selected patients were analysed by an 
expert pathologist at the hospital. 
Immunohistochemistry of conventional tissue sections 
of cervix (HPV – and HPV+ samples) 
Cervical biopsies were taken from the TZ in CIN I 
patients and from equivalent areas in control (hysterec
tomy) women. Samples were then placed in sterile Eppen
dorf vials (Eppendorf North America, New York, NY, 
USA) with 500 ll of endotoxin free sterile saline solution 
(SS) and maintained on ice until use; a small piece was 
then cut and placed in tissue tek (Sakura Finetek, Tor
rence, CA, USA) and kept frozen at )70� until immuno
labelling procedures took place. Once 5 lm tissue 
sections had been prepared, ﬁxed with cold acetone for 
7 min, and blocked with Universal Blocking Solution 
(BioGenes, San Ramon, CA), primary Abs were used at 
optimal dilutions, which were previously determined. Ab 
to MHC CII (DR) (Dako, Carpinteria, CA) was used at a 
dilution of 1 : 50, and Ab to L1 (Pharmingen, San Diego, 
CA) was used at a dilution of 1 : 50. This Ab recognizes 
L1 from HPV16, although it may cross react with HPV
33, but not with HVP 6 or HPV 11. Both Abs were left 
to react overnight at 4�. After thorough washing of the 
sections, procedures were then exactly the same as for 
epithelial sheets undergoing immunohistochemistry. A 
secondary Ab, peroxidase conjugated horse anti mouse 
immunoglobulin (Vector, Burlingame, CA), was added in 
a 50 ll volume and incubated at room temperature for 
1 hr; after three more washes, bound Abs were revealed 
using diaminobenzidine (DAB) as chromogen, observed 
as a dark brown colour. The reaction was stopped by 
washing in running water, mounting media was added 
and the slides were coverslipped before analysis. 
Preparation of epithelial sheets from human cervix 
Once the biopsies were taken, they were placed in a sterile 
Eppendorf vial containing 500 ll of endotoxin free sterile 
SS, and placed on ice until their preparation in the laborat
ory, which usually took less than 3 hr. Once in the laborat
ory, samples were cut into two main portions; the smallest 
was placed in tissue tek and frozen until sectioning for 
immunohistochemistry, as described below, while the lar
gest portion was placed, lumen side up, in an enzymatic 
cocktail containing collagenase dispase, for 15 20 min at 
30�. After this incubation period, the epithelial layer was 
separated by gentle traction with ﬁne forceps, stretched 
very carefully and washed three times in sterile SS contain
ing 1% bovine serum albumin (SS + 1% BSA), ﬁxed in 2% 
paraformaldehyde for 20 min and then washed extensively 
before initiating the immunohistochemistry procedures. 
Immunohistochemistry of cervical epithelial layers 
to assess DC in situ 
Each epithelial layer was divided into small pieces in 
order to have at least three portions for testing each Ab. 
The following monoclonal antibodies (mAbs) were used: 
anti DR (Dako) at a dilution of 1 : 50; anti CD1a (Dako) 
at a dilution of 1 : 50; and anti Langerin (LIR, Dardilly, 
France) at a dilution of 1 : 50. For each set of experi
ments, an isotype matched, irrelevant control Ab was also 
included. These Abs were applied overnight at 4�, in a  
ﬁnal volume of 50 ll per well, for each set of cervical epi
thelial sheets. Then, epithelial sheets were washed three 
times in SS + 1% BSA, and secondary Ab (peroxidase
conjugated horse anti mouse immunoglobulin) (Vector, 
Burlingame, CA) was added in 50 ll of SS + 1% BSA 
and incubated at room temperature for 1 hr. After wash
ing three times in SS + 1% BSA, bound Abs were 
revealed using, as chromogen, DAB, observed as a dark 
brown colour. Once the reaction was stopped, epithelial 
layers were stretched to make them as ﬂat as possible, 
immunomount solution was added, and the slides were 
coverslipped and analysed using a Carl Zeiss microscope. 
At least 20 different ﬁelds were evaluated for each differ
ent portion of epithelial sheet obtained. 
Hybrid capture system to identify the group 
of high-risk HPV 
A small piece of the cervix sample was placed in Digene 
hybrid capture transport medium (Digene Diagnostics 
Inc., Silver Springs, MD), following the manufacturer’s 
instructions. Samples were then incubated in denaturation 
reagent to produce single stranded DNA. The HPV RNA 
probe cocktails for high risk HPV were added with either 
control or test samples and allowed to hybridize at 65� 
for 1 hr. The hybridized DNA RNA was then placed into 
tubes coated with anti hybrid immunoglobulin, and 
immobilized hybrids were then incubated with alkaline 
phophatase tagged Abs. After incubation and subsequent 
washing, the Lumi Phos detection reagent was added to 
each tube, the tubes were incubated for 30 min at room 
temperature, after which they were read using a lumino
meter. Each set of samples was run with the positive and 
negative controls provided by the hybrid capture kit. 
Results are expressed as relative light units (RLU) and 
represent the mean of triplicate readings for each sample. 
Data analysis 
Mean values and standard deviations were calculated for 
numerical variables. The Mann Whitney test was per
formed to compare the DC density with positive markers 
between study groups (HPV+ and HPV– controls). All 
results were viewed as signiﬁcant if P < 0�05. Bivariate 
correlation between DC density with the age of patients, 
and DC density with the study group, were analysed 
using Spearman’s rho non parametric test. In order to 
evaluate both independent variables as predictors of DC 
density, we used a linear regression by enter method. The 
data were analysed using the software Statistics Profes
sional Social Science (SPSS�) version 10 for Windows� . 
Results 
Histology of conventional tissue sections and 
identiﬁcation of MHC-CII (DR)+ cells in normal 
cervix 
We ﬁrst evaluated the normal histological appearance of 
the cervix region, especially around the TZ. In Fig. 1(a), 
the epithelium (upper part) is readily distinguishable 
from the stroma (lower part). Likewise, cells labelled for 
MHC CII are clearly apparent, especially in the basal cells 
of the epithelium (arrows in Fig. 1b,c). Occasionally, the 
cut permits that one of these MHC CII+ cells might 
resemble a DC (arrow in Fig. 1c), although their mor
phology in the sections does not allow such a precise dis
tinction to be made. 
Cervical epithelial sheets as an appropiate tool 
for in situ assessment of genital tract DC 
By means of enzymatic treatment, we successfully adapted, 
to freshly taken cervix samples, the approach of epidermal 
Figure 1. Basic histology and major histocompatibility complex 
(MHC) CII (DR)+ cells in conventional tissue sections of human 
papilloma virus (HPV) negative cervix. Cervix samples obtained from 
high risk HPV negative women were frozen, and conventional tissue 
sections were stained with haematoxylin (a) and with a monoclonal 
antibody to MHC II (DR) (b, c). The epithelium is clearly distinguish
able from the underlying stroma (a; ·10 magniﬁcation). In this 
section, bound MHC II antibody was revealed with peroxidase and 
diaminobenzidine (DAB), as a brown colour (b, c). Brown MHC
CII+ cells are clearly evident around the lower stratum of the cervix 
epithelium (arrows in panel b; ·20 magniﬁcation). In some 
of these cells, a dendritic appearance was revealed (arrow in panel c; 
·40 magniﬁcation). 
tissue upon this treatment were, indeed, useful for exam
ining the DC morphology. Indeed, by using this approach 
sheet separation. The epithelial layers obtained from cervix it was possible to evaluate not only individual DC, each 
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Figure 2. Cervical epithelial sheets reveal cells with prominent dend
ritic morphology and a regular pattern of distribution. Fresh cervix 
biopsies were subjected to enzymatic treatment to separate epithelial 
layers in order to perform immunohistochemistry with antibodies to 
CD1a (a, b, d) and major histocompatibility complex (MHC) CII 
(DR) (c). A dense network of strongly positive cells with notorious 
dendritic appearance is clearly revealed in epithelial sheets from cer
vix tissue. Likewise, a regular pattern of distribution is readily 
observable (a). Not only the morphology of individual, complete 
cells can be assessed, but also single dendrites in each DC (c and d, 
arrows). (a) ·10 magniﬁcation; (b) and (c) ·40 magniﬁcation; 
(d) ·100 magniﬁcation. 
one complete, but also the extension and the arrangements 
of single dendrites in a given cell (arrows in Fig. 2c,d). 
This was also a very convenient means of assessing whe
ther DC showed any peculiar pattern of distribution in the 
cervix, which would not be possible to determine using 
conventional tissue sectioning. For instance, a dense net
work of DC in a planar like arrangement was revealed 
with each of the Abs used (Fig. 2a; CD1a staining). 
Indeed, the DC topography shown with these three mark
ers revealed that DC are not randomly scattered along the 
cervix epithelium, but instead are regularly distributed 
(Fig. 2a), like DC in the skin. In fact, both the morphol
ogy and the regular pattern of distribution resembled very 
much that of the epidermal Langerhan’s cells (LC), and 
was manifested through each of the three Abs used: DR, 
CD1a and Langerin (Fig. 3a c). However, as in the skin, 
cervical DC were more obviously dendritic when revealed 
with MHC II DR and CD1a than with Langerin, which, 
perhaps owing to the staining of the soma, did not pro
vide such a prominent dendritic appearance, but instead 
delineated well the DC body (Fig. 3c). 
HPV+ CIN-I versus HPV – (control) samples 
By means of the hybrid capture method, a small portion 
of freshly obtained tissue was used to assess the presence 
of high risk HPV (nine types of mucotropic HPV). It was 
clear that most samples of the clinically preselected 
Figure 3. Dendritic cells (DC) in cervical epithelial sheets of human 
papilloma virus negative (HPV ) and human papilloma virus posit
ive (HPV+) patients. Epithelial layers of cervix samples obtained 
from HPV  and HPV+ cervical intraepithelial neoplasia I (CIN I) 
patients were used to assess the morphology, distribution and fre
quency of DC with antibodies to CD1a (a and d), major histocom
patibility complex class II (MHC II) (DR) (b and e) and Langerin 
(c and f); (a) (f), ·40 magniﬁcation. Apart from quantitative and 
morphological changes, the regular pattern of DC distribution was 
also modiﬁed in the HPV infected samples (d f). The morphology 
of Langerin+ cells was clearly altered in HPV+ sheets (f) compared 
with HPV  samples (c). 
patients (CIN I stage) provided a very strong signal for 
high risk HPV in the luminometer readings, and only a 
few (four) gave a weak, but positive, signal (Fig. 4, black 
bars). It was also evident that for the samples taken from 
control patients, readings were clearly negative in this sys
tem (Fig. 4, white bars), thus correlating well with all the 
criteria (clinical, laboratory tests and cyto pathology) used 
for preselecting both groups. 
Samples from HPV+ cervix express, in situ, abundant 
L1 protein of HPV16 and koilocytosis 
Frozen sections of fresh cervix biopsies from HPV+, CIN
I grouped women, were subjected to immunohistochem
istry using Abs to L1 of high risk HPV16. Numerous epi
thelial cells from these HPV+ samples were found to 
strongly express L1 HPV16 protein, and the positivity 
increased towards the lumen Fig. 5(b d). Basal cells of 
the epithelium, at the lower stratum, and also cells in the 
underlying stroma, were L1 negative (Fig. 5b). The cells 
termed koilocytes were also evident in the tissue 
(arrows in Fig. 5c,d), thus verifying the cellular manifesta
tions typical of these early epithelial lesions during HPV 
infection. 
Reduction of DC frequency in cervix layers 
of HPV+ patients 
Once the immunolabelling of DC in cervical epithelial 
sheets had been established, we performed a comparison 
between DC in epithelial layers obtained from control, 
HPV negative cervix tissue and samples from high risk 
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Figure 4. Cervical intraepithelial neoplasia (CIN) I samples, but not 
control samples, are positive for high risk human papilloma virus 
(HPV). Fresh tissue samples from cervix were evaluated for the pres
ence of the high risk HPV by using the hybrid capture system. 
Women (n  16) were ﬁrst preselected using multiple criteria (clin
ical, laboratory tests and cyto pathology), and samples were tested 
for the presence of DNA of the high risk HPV group. Control sam
ples were from hysterectomy performed for benign conditions in 
n  5 women, showing normal results using the same clinical and 
cyto pathology criteria. Control samples (left side of the ﬁgure) were 
all negative for the presence of high risk HPV, while the 16 CIN I 
preselected samples were positive for high risk HPV (right side of 
the ﬁgure). Most CIN I samples were strongly positive. The results 
are expressed as relative light units (RLU) and represent the mean of 
triplicate readings for each sample. 
Figure 5. L1 protein expression and koilocytosis in human papil
loma virus (HPV)+ cervical intraepithelial neoplasia I (CIN I) cervix. 
Cervix samples from CIN I grouped women were subjected to im
munohistochemistry using antibodies to the L1 protein of HPV16. 
Abundant cells in the tissue strongly express the L1 protein, especi
ally towards the upper stratum of the epithelium (b d), while basal 
epithelial cells and stromal cells are negative (b). Likewise, koilocyto
sis, a typical cytopathic response of early infection, is easily observed 
in the HPV infected epithelium (arrows in c and d). (a) HPV+ epi
thelium labelled with an irrelevant isotype matched control anti
body. (a) ·10 magniﬁcation; (b) ·20 magniﬁcation; (c) and (d) ·100 
magniﬁcation. 
HPV+ women. As shown in Fig. 3(d f) and Fig. 6, DC 
were less numerous in samples prepared from HPV+ 
women than in epithelial sheets obtained from non infec
ted cervix samples. In fact, at � 50%, DC reduction was 
similar for all three markers (Fig. 6). Statistically signiﬁ
cant differences between the HPV – and the HPV+ groups 
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Figure 6. High risk human papilloma virus (HPV) infection reduces 
the number of dendritic cells (DC) in human cervix. Epithelial layers 
from freshly obtained cervix samples were used to quantify the DC 
frequency per area in all tissue samples obtained from both control 
HPV  (white bars) and HPV+ (grey bars) women. Assessment was 
performed for each of the three markers [major histocompatibility 
complex class II (MHC II), CD1a and Langerin], and the results rep
resent the mean value plus standard error of all quantiﬁcations per
formed, at least in triplicate, on each sample from all the women 
examined. (*P < 0 001). 
tion between the DC frequency with the age of patients 
was low and similar for all markers, at � 0�40. The corre
lation between the DC density with the variable study 
groups was 0�59 for MHC II, 0�61 for CD1a and 0�51 for 
Langerin. Standardized coefﬁcients obtained with linear 
regression were as follows: 0�64 for MHC II when group 
variable was the predictor, and 0�02 for age; 0�69 for 
CD1a with group variable as the predictor, and 0�01 for 
age; and 0�51 for Langerin with group variable as the pre
dictor, and 0�12 for age. 
Altered morphology of Langerin+ DC in HPV+ cervix 
Langerin staining in epithelial sheets from cervix depicted 
mainly the cell soma of DC, rather than providing a 
clearly delineated dendritic morphology like that observed 
with MHC II+ or CD1a+ DC. It was interesting therefore 
to ﬁnd that Langerin staining revealed a prominent dend
ritic appearance (Fig. 3f) only in HPV+ samples, perhaps 
indicating signs of DC activation in situ. 
Discussion 
Although there are a number of reports of DC in the 
HPV infected human female genital tract, especially in 
the cervix, these appear to be contradictory because some 
describe no changes, some have found a decreased num
ber of DC and others have seen increased DC num
bers.18–21 Various reasons have been suggested for these 
discrepancies. 
(1) The precise histological locations where the biopsies 
were found for all three markers examined. The correla were taken might have been different. 
(2) The disease stages of the HPV infected samples exam
ined may have been different. 
(3) Most studies used only single, but different, markers 
to identify DC: most used S 100; others used were 
MHC CII22 and ATPase. Fewer have used CD1a,23 
and we know of no studies that have used the Lang
erhans’ cell restricted marker, Langerin. Furthermore, 
to the best of our knowledge there are no descriptions 
of these three DC markers (MHC CII, CD1a, Lang
erin) evaluated together. 
(4) The methodological approach used to perform these 
evaluations should also be taken into account. As far 
as we know, researchers have used mostly conven
tional tissue sections not only to identify DC, but also 
to quantify them. However, we believe that for accu
rately assessing DC, at least three different criteria 
(evident dendritic morphology, topographic distribu
tion within tissues and, perhaps more important for 
these studies, DC quantiﬁcation) should be used. The 
use of cervical epithelial sheets is more appropriate 
than conventional tissue sectioning. We believe this 
because, if DC are arranged in a planar like layer 
(which they seem to be in mucosae and skin) in a 
rather uniform distribution, only those parts of a DC 
body traversed by the cut will be visualized during 
immunolabelling. In contrast, epithelial sheets, by 
providing an en face view of each complete cell, are a 
very convenient means of simultaneously assessing 
morphology (even at the level of a single cell and a 
single dendrite, arrows in Fig. 2c,d), the pattern of 
DC distribution and optimizing their quantiﬁcation 
per tissue area. Moreover, it is also important to con
sider that cervical epithelial sheets, not undergoing 
the process of parafﬁn embedding and not being fro
zen, but freshly prepared and immediately ﬁxed, are 
more likely to provide a closer approximation of how 
the tissue and the cells might be in reality. In fact, it 
was readily observed that DC in the cervix epithelium 
are not randomly scattered, and they do not seem to 
be clustered in certain areas along the epithelium. 
Instead, they were found to exhibit a rather regular 
and uniform pattern of distribution, resembling very 
much that of cutaneous LC in epidermal sheets 
(Fig. 2a). Moreover, this regular pattern of distribu
tion was revealed with all of the three DC markers 
used (CII, CD1a and Langerin), although with differ
ent morphological appearances, especially for Lang
erin+ cells. 
We are interested in studying in situ the local, regional 
immune responses in the female genital tract, especially 
during the development of the early premalignant stages 
of HPV infection. We have therefore chosen to initiate 
these studies with women positive for the group of vir
uses associated with cervical carcinoma  the high risk 
HPV group  and we chose to study only patients categ
orized as having CIN I. Although this stage represents a 
premalignant lesion appearing early during HPV infec
tion, these lesions express viral proteins. Usually these 
lesions will be associated with peculiar cellular manifesta
tions, termed koilocytosis (a cytopathic consequence of 
the early viral infection), which appear in the TZ. Indeed, 
koilocytes were readily observed in the cervical epithelium 
of our HPV+ samples examined (arrows in Fig. 5c,d). 
Furthermore, positivity was also manifested for the L1 
viral protein (but not for the E7 viral protein; data not 
shown) (Fig. 5) in the epithelium of seven of the samples 
examined, being stronger towards the lumen. However, in 
these same samples in which a strong positivity for the 
viral protein L1 was revealed, no labelled cells exhibited 
an apparent dendritic morphology (Fig. 5b). Furthermore, 
no L1 positive cells were seen in the area where MHC II+ 
cells were located (Figs 1b and 5b). This suggests that 
high risk HPV infection, at least in an early premalignant 
stage, such as CIN I, does not reach or target these local 
APC; more detailed research is needed to elucidate this. 
In fact, it is known that mature HPV virions are pro
duced at the most external cell layers of the cervix and 
released into the lumen. HPV progeny are shed into the 
environment with epithelial squamae, therefore preclu
ding useful contacts with cells of the local or the systemic 
immune system, somehow making the host immunologi
cally unaware of the infection.6,7 
We do not have a precise explanation for the decrease 
of DC found in the HPV infected cervix, although several 
possibilities exist, including: reduction of the DC (or their 
immediate precursors) colonizing this area; increased exit
ing or trafﬁc of the normally resident cells; or promoted 
DC death. We believe that the last possibility, although 
possible, is less likely to occur because HPV is known to 
induce proliferation rather than cell death, at least in epi
thelial cells.6 We are currently examining these possibilit
ies. The mean age of the HPV+ CIN I group was 
32�5 years and that of the control HPV– hysterectomy 
group was 42�5 years. Because of ethical constraints it was 
not feasible to biopsy healthy women of younger age with 
no medical justiﬁcation. However, the correlation between 
DC density and age was low and similar for all markers. 
Additionally, the standardized coefﬁcients of multivariant 
analysis indicate that the observed changes in DC fre
quency were not related to age, but to the HPV infection 
status. Moreover, in another epithelium, such as the skin, 
DC frequency has been reported to be substantially 
reduced in the elderly,24 not increased. If there were any 
parallel between these two epithelia, the skin report indi
rectly supports our ﬁndings in the cervix because the 
decreased DC frequency was found in the younger 
(HPV+ CIN I), and not in the older (hysterectomy, con
trol), age group. 
Regarding the potential meaning and consequences of 
the low DC frequency found in the cervix samples of all 
patients infected with high risk HPV, as DC are the most 
peripheral sentinel cells of the immune system and are 
crucial for delivering appropriately processed antigenic 
information to T cells, this may represent one of many 
viral subversion stratagems given that the three markers 
used to identify the DC (MHC CII, CD1a and Langerin), 
are all importantly involved in Ag capturing, processing 
and presentation. Conceivably, a consequence of this 
could be a more permissive microenvironment for the 
HPV to initiate and establish infection within the regional 
tissue. On the one hand, local DC deﬁciency is likely to 
impede efﬁcient T cell recruitment into this microenvi
ronment. On the other hand, local DC deﬁcit might also 
hamper the efﬁcient ferrying of Ag into regional lymph 
nodes, thus further interfering with the development of 
effective cytotoxic T cell responses. Another important 
fact to consider is that not only the quantity of DC was 
decreased in the HPV infected cervix; HPV might also 
affect the early process of DC activation because, in these 
same samples where MHC II+, CD1a+ and Langerin+ cells 
were readily identiﬁed, we were unable to demonstrate 
DC expressing CD40 (not shown), a molecule well known 
to be induced by different stimuli during the normal pro
cess of DC activation and maturation. It is thus intriguing 
that precisely within the cervical tissue microenvironment 
where the HPV infection naturally occurs, there are fewer 
DC and those remaining might not be activated and may 
not be actually infected. Viral infection during these early 
stages (CIN I) might therefore interfere with establishing 
a local tissue microenvironment appropriate to the subse
quent development of efﬁcacious T cell responses, pos
sibly facilitating, in this way, the progression of these 
early lesions into carcinomas. According to some,6 HPV 
infection might thus create a localized immunodeﬁcient 
microenvironment, especially in the TZ. Perhaps all of 
these different contributing factors may help to explain 
the reports on the intriguing ﬁndings that apparently 
many patients lack CTL reactivity, even after long periods 
(months or years) of documented HPV infection.6,7 More 
research is certainly required, ﬁrst in order to obtain a 
better picture of the early responses of the local immune 
system and the potential viral subversion strategies and, 
second, to try to develop better therapeutic or prophylac
tic approaches for this cancer of infectious origin. 
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